Harvard Apparatus ECM 2001+, Hybridoma Production System

The Harvard Apparatus ECM 2001+, Hybridoma Production System is a high-performance electroporation device designed for hybridoma cell fusion and monoclonal antibody production. It features precise control over electroporation parameters and includes coaxial chambers with identical electrical properties, enabling seamless scale-up from optimisation to production. A transparent-bottom optimisation chamber allows visual monitoring of cell alignment under an inverted or standard microscope, making it ideal for immunology and biotechnology applications.

Key Features:

• Brand: Harvard Apparatus
• Model: ECM 2001+
• Application: Ideal for hybridoma generation and monoclonal antibody production
• Control: Accurate pulse control for optimal cell fusion
• Design: Reliable and reproducible results for immunology and biotechnology applications
• Chamber Compatibility: Coaxial chambers with identical electrical properties for direct scale-up
• Visualization: Transparent-bottom optimisation chamber enables visual monitoring of cell alignment

Scope of Supply:

• ECM^® 2001+ Generator
• Coaxial optimisation chamber (2 ml)
• Coaxial production chamber (9 ml)
• Adapter set
• Cytofusion medium C (500 ml)

This system is an essential solution for laboratories focused on efficient monoclonal antibody development and high-yield hybridoma production.

Frequently Asked Questions

1. What is the Harvard Apparatus ECM 2001+, Hybridoma Production System used for?

It is a high-performance electroporation device designed for hybridoma cell fusion and monoclonal antibody production. It features precise control over electroporation parameters and includes coaxial chambers with identical electrical properties, enabling seamless scale-up from optimisation to production. A transparent-bottom optimisation chamber allows visual monitoring of cell alignment under an inverted or standard microscope, making it ideal for immunology and biotechnology applications.

2. Is the Harvard Apparatus ECM 2001+, Hybridoma Production System suitable for hybridoma generation and monoclonal antibody production?

Yes. It is designed for hybridoma generation and monoclonal antibody production, and offers accurate pulse control for optimal cell fusion and reliable and reproducible results for immunology and biotechnology applications to support this kind of work.

3. What control and design does the Harvard Apparatus ECM 2001+, Hybridoma Production System have?

It has accurate pulse control for optimal cell fusion, reliable and reproducible results for immunology and biotechnology applications and coaxial chambers with identical electrical properties for direct scale-up, and is supplied under manufacturer part number 452048.

4. What visualization does the Harvard Apparatus ECM 2001+, Hybridoma Production System offer?

It offers transparent-bottom optimisation chamber enables visual monitoring of cell alignment, ECM® 2001+ Generator, coaxial optimisation chamber (2 ml) and coaxial production chamber (9 ml).

5. How does the Harvard Apparatus ECM 2001+, Hybridoma Production System compare with the DWK Wheaton R2P™ 2.0 Roller Machine, Production System, Bottom Drive, 11 Fixed Decks, 8 Positions per Deck, with Cable for Europe from DWK?

The Harvard Apparatus ECM 2001+, Hybridoma Production System is a strong choice when chamber compatibility of Coaxial chambers with identical electrical properties for direct scale-up matches the workflow. The DWK Wheaton R2P™ 2.0 Roller Machine, Production System, Bottom Drive, 11 Fixed Decks, 8 Positions per Deck, with Cable for Europe is an alternative offering power compatibility of Includes cable suitable for European electrical standards, so the preferred option depends on the required specification and compatibility.